Skip to main content

Insights

Producing knowledge to cure disease

A man in a blue button down shirt and tie examines a microscope slide in a laboratory setting.

Kevin Tracey, MD, explained the structure and work of the Feinstein Institutes in a LEADERS Magazine interview

As President and CEO of Northwell Health’s research arm, the Feinstein Institutes for Medical Research, Kevin Tracey, MD, oversees research for the health system. He is a leader in the study of the molecular basis of inflammation, bioelectronic medicine and vagus nerve stimulation. He discovered how the brain and vagus nerve control the inflammatory response to infection and injury, and invented a method to use electronic devices to replace anti-inflammatory drugs.

Dr. Tracey spoke to LEADERS Magazine about the tradition of medical research to which the Feinstein Institutes belong and the discoveries currently taking place in the system.

Will you highlight the work of the Feinstein Institutes for Medical Research?

The Feinstein Institutes celebrates a special focus on mission and on excellence. Recall Albert Einstein’s quote: “If we knew what it was we were doing, it would not be called research, would it?” 

So when you think about doing research in the context of curing disease, we have to confront the reality that there is much we do not understand about many illnesses, and this puts cures out of reach. However, at the Feinstein Institutes we, and our colleagues in science worldwide, are creating new and more powerful tools that we can use to reveal the mechanisms of disease. That is the point — to cure a disease, you need to focus on unraveling the underlying molecular mechanisms. At the beginning of the process, there are many unknowns, and you go up a lot of alleys to find out if they are, indeed, blind. But by focusing on a problem that we are trying to solve, and persisting for years or decades, my colleagues at the Feinstein Institutes bridge the knowledge gap in four important ways:

  • Produce knowledge to cure disease
  • Publish and share expertise with the global scientific and medical communities
  • Collaborate across labs, disciplines and with other institutions
  • Deliver new discoveries to the bedside through clinical trials

Will you provide an overview of the five Institutes that make up the Feinstein Institutes for Medical Research?

The Feinstein Institutes was founded in 1999 as a research home for what was then North Shore-LIJ Health System, which grew and expanded to become Northwell Health. The Feinstein Institutes has expanded and grown to consist of approximately 100 research labs and programs, 3,000 clinical research studies, and 8,000 researchers and staff. We have organized this work around five institutes:

How critical has it been to maintain the culture of the Feinstein Institutes for Medical Research as the organization has grown and expanded its work?

The Feinstein Institutes is known for two things: its focus on mission and its collaborative culture. In order to maintain this over nearly 25 years of growth and expansion, it has been critical to maintain a focus on excellence. This happens by recruiting leaders in their field who are committed to the mission themselves, are excellent in what they do, and who are collaborative. 

When we recruit and hire, we focus not so much on the position they play, or the role they fill, but on who is the best talent committed to the mission and collaboration. We are constantly looking for the best of the best, and equally persistent in our commitment to sustaining an environment that supports the Feinstein Institutes faculty to be maximally productive as a valued team member.

Will you provide an example of the exciting research taking place at the Feinstein Institutes?

The Feinstein Institutes are well-known for its leadership in the areas of focus for the five Institutes. One example that has garnered a great deal of interest recently is in bioelectronic medicine. Our research shows that inflammation can be controlled through the vagus nerve, the main “highway” of neural information between the brain and body. Our Institute of Bioelectronic Medicine’s work in neuroscience, immunology and biomedical engineering led to clinical trials of new devices to treat inflammation and reverse serious illnesses, including rheumatoid arthritis, inflammatory bowel disease and depression. One exciting aspect of using bioelectronic medicine devices is that this has the potential to supplement or even replace some drugs, and to eliminate or reduce their high cost and potentially debilitating side effects.

What excited you about the opportunity to join the Feinstein Institutes for Medical Research and has it been what you expected?

My tenure at the Feinstein Institutes has exceeded my own high hopes for organizational success. It has been wonderful to work with colleagues in science, medicine and administration dedicated to helping others by seeking knowledge and cures. These are the best people in the business, collaborating together, bound by a shared mission, and working to accomplish a special goal. If you think back at what has happened in the last 25 years, whether it was a recession, financial collapse, or pandemic, many of the obstacles that have been encountered along the way were quite significant, but when you look at the growth and accomplishments of our five Institutes, I believe we had the advantage of being relatively new. We built and grew unburdened by hundreds-year-old traditions and ancient precedents. We built a new, collaborative culture, in current times, so that our work could bring us all into a future with new cures.

How valuable has it been to have such an engaged and committed board for the Feinstein Institutes for Medical Research?

The irreplaceable support of our board members and the Northwell Health system under the leadership of Michael Dowling and his passion for the Feinstein Institutes’ work and mission have all been the wind beneath our wings. When you put all this support together, you have tremendous, irreplaceable assets that have made all the difference for our success.

What do you tell young people about a career in medical research?

I tell them that the world changes one individual at a time. I tell them the story of Joseph Meister who was nine years old when he was bitten by a rabid dog in Paris. Before Joseph Meister, every person that contracted rabies died. But young Joseph Meister was fortunate, because he was treated by Louis Pasteur, who had invented a new therapy, and Joseph lived. I tell young people today, because of not only the rabies vaccine, but all the other vaccines that have come from that, we live in a different world. Every first research patient starts a new world, and the Feinstein Institutes have lots of first patients. I tell young people that it is a blessing and a privilege to pursue this career – a career where you learn something new every day, in a collaborative environment, that produces knowledge to help people. There is no more noble career path, one that is not only fulfilling and rewarding, but is committed to making the world a better place.

Related news
Vagus nerve stimulation (VNS) could revolutionize the treatment of chronic inflammation, helping you live a longer, healthier life — one free from chronic diseases.
How vagus nerve stimulation can ease inflammation in the body — and why that matters to our mental health.
How vagus nerve stimulation could offer a drug-free option for treating obesity.

Our representatives are available to schedule your appointment Monday through Friday from 9am to 5pm.

For a Northwell ambulance, call
(833) 259-2367.